Safety and efficacy of patiromer use with tacrolimus in kidney transplant recipients

Transpl Int. 2019 Jan;32(1):110-111. doi: 10.1111/tri.13369. Epub 2018 Nov 15.

Authors

Rungwasee Rattanavich¹, Andrew F Malone¹, Tarek Alhamad¹

Affiliation

¹ Division of Nephrology, Washington University School of Medicine, St. Louis, MO, USA.

PMID: 30444015
DOI: 10.1111/tri.13369

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Cations
Delayed Graft Function / prevention & control
Diabetic Nephropathies / complications
Diabetic Nephropathies / surgery
Female
Glomerulonephritis, IGA / complications
Glomerulonephritis, IGA / surgery
Graft Rejection / prevention & control*
Humans
Hyperkalemia / drug therapy
Immunosuppressive Agents
Kidney Failure, Chronic / surgery
Kidney Transplantation*
Male
Middle Aged
Patient Safety
Polymers / administration & dosage*
Tacrolimus / administration & dosage*
Transplant Recipients
Treatment Outcome

Substances

Cations
Immunosuppressive Agents
Polymers
patiromer
Tacrolimus